Woman's 18-year CAR T-cell remission
This is a US news story, published by Guardian, that relates primarily to CAR news.
US news
For more US news, you can click here:
more US newsbiology news
For more biology news, you can click here:
more biology newsGuardian news
For more news from Guardian, you can click here:
more news from GuardianAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
neuroblastoma. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cell therapy news, brain tumour news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
tumour immunologyGuardian
•Science
Science
Woman who had pioneering cancer treatment 18 years ago still in remission
87% Informative
Therapy involves taking T-cells, a type of white blood cell, from a patient and genetically engineering them to target and kill cancer cells.
Known as CAR (chimeric antigen receptor) T-cell therapy, the approach has proved particularly successful in treating certain types of blood cancers.
Next-generation forms of the therapy have been approved for such cancers in the US and UK .
But response rates have been less encouraging in solid tumours, with long-term outcomes unclear.
VR Score
91
Informative language
92
Neutral language
49
Article tone
informal
Language
English
Language complexity
52
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
5
Source diversity
5
Affiliate links
no affiliate links